Melanin concentrating hormone receptor antagonist
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 7, 2009
Grant Date -
Sep 29, 2005
app pub date -
Aug 11, 2004
filing date -
Aug 13, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel compounds, or pharmaceutically-acceptable salts, tautomers or prodrugs thereof, of Formula Iare as defined in the specification, are provided. Also provided are methods of treating or preventing a melanin concentrating hormone-mediated disorder in a subject, comprising administering to a subject in need of such treatment or prevention a compound of Formula I.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully